Schedule 13D ownership disclosure
AMAG PHARMACEUTICALS INC.
Security class unavailable · CUSIP: 00163U106
Event date: 2019-08-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-19-003418
- Form type
- SC 13D
- Filer
- AMAG PHARMACEUTICALS, INC.
- CIK
- CIK 792977
- Filed
- Aug 15, 2019
- Reporting period
- Aug 06, 2019
- Description
- Schedule 13D beneficial ownership